Get started
Author

Mı́riam Tendler

Observed names: M Tendler, M. Tendler, Miriam Tendler, Míriam Tendler, Míriam Tendler, Tendler, Miriam, Tendler,Miriam
ORCID: 0000-0002-9471-7461
Observed ORCID: 0000-0002-9471-7461
OpenAlex ID: A5033599962
A Schistosoma mansoni fatty acid-binding protein, Sm14, is the potential basis of a dual-purpose anti-helminth vaccine.
1996 · M Tendler, C A Brito, et al. · Proceedings of the National Academy of Sciences · 228
PDF
A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins
1991 · D. Moser, M. Tendler, et al. · Journal of Biological Chemistry · 165
Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults
2015 · Marilia Santini-Oliveira, Rhea N. Coler, et al. · Vaccine · 115
The biotechnology-value chain: Development of Sm14 as a schistosomiasis vaccine
2008 · Miriam Tendler, Andrew J.G. Simpson · Acta Tropica · 84
Schistosoma mansoni: Vaccination with adult worm antigens
1986 · Miriam Tendler, R.Magalhães Pinto, et al. · International Journal for Parasitology · 71
RecombinantMycobacterium bovisBCG Expressing the Sm14 Antigen ofSchistosoma mansoniProtects Mice from Cercarial Challenge
2004 · Paula B. Varaldo, Luciana C. C. Leite, et al. · Infection and Immunity · 53
Vaccination against Fasciola hepatica infection using a Schistosoma mansoni defined recombinant antigen, Sm14
2003 · Marília S. Almeida, Humberto Torloni, et al. · Parasite Immunology · 51
Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine
2018 · Miriam Tendler, Marilia S. Almeida, et al. · Tropical Medicine and Infectious Disease · 47
PDF
Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant
2015 · Miriam Tendler, Marilia Almeida, et al. · Frontiers in Immunology · 47
PDF
An experimental bivalent peptide vaccine against schistosomiasis and fascioliasis
2003 · Mônica Magno Vilar, Frank Barrientos, et al. · Vaccine · 44
Gene Structure and M20T Polymorphism of theSchistosoma mansoni Sm14 Fatty Acid-binding Protein
2003 · Celso Raul Romero Ramos, Rita Cassia Rossi Figueredo, et al. · Journal of Biological Chemistry · 39
PDF
Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: Structural and functional characterization of a vaccine candidate
2008 · Celso R.R. Ramos, Alberto Spisni, et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 36
Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen
2010 · Ricardo E Mendes, Rafael Zafra, et al. · Memórias do Instituto Oswaldo Cruz · 34
PDF
r-Sm14 - pRSETA efficacy in experimental animals
2001 · Celso Raul Romero Ramos, Mônica Magno Vilar, et al. · Memórias do Instituto Oswaldo Cruz · 34
PDF
Vaccination against schistosomiasis and fascioliasis with the new recombinant antigen Sm14: potential basis of a multi-valent anti-helminth vaccine?
1995 · Miriam Tendler, Monica Magno Vilar, et al. · Memórias do Instituto Oswaldo Cruz · 34
PDF
Genetic variability analysis among clinical Candida spp. isolates using random amplified polymorphic DNA
2004 · Patrícia M Pinto, Maria A Resende, et al. · Memórias do Instituto Oswaldo Cruz · 32
PDF
rDNA-RFLP identification ofCandidaspecies in immunocompromised and seriously diseased patients
2004 · Patrícia M Pinto, Maria A Resende, et al. · Canadian Journal of Microbiology · 24
Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women
2022 · Marilia Santini-Oliveira, Patrícia Machado Pinto, et al. · Vaccines · 21
PDF
Sm14 of Schistosoma mansoni in Fusion with Tetanus Toxin Fragment C Induces Immunoprotection against Tetanus and Schistosomiasis in Mice
2004 · Patrícia A. E. Abreu, Patrícia A. Miyasato, et al. · Infection and Immunity · 21
Schistosoma mansoni-New Zealand Rabbit Model: Resistance Induced by Infection Followed by Active Immunization with Protective Antigens
1991 · Miriam Tendler, Marilia S. S. Almeida, et al. · Journal of Parasitology · 18
Vaccine value profile for schistosomiasis
2024 · Gavin Yamey, Kaci Kennedy McDade, et al. · Vaccine · 17
Mycobacterial codon optimization of the gene encoding the Sm14 antigen ofSchistosoma mansoniin recombinantMycobacterium bovisBacille Calmette-Guérin enhances protein expression but not protection against cercarial challenge in mice
2006 · Paula B. Varaldo, Eliane N. Miyaji, et al. · FEMS Immunology & Medical Microbiology · 16
PDF
Schistosoma mansoni: protective antigens
1987 · Miriam Tendler · Memórias do Instituto Oswaldo Cruz · 14
PDF
Schistosoma mansoni: comparative evaluation of different routes of experimental infection
1985 · M. Tendler, R. Magalhães Pinto, et al. · Revista do Instituto de Medicina Tropical de São Paulo · 14
PDF
Letter to the Editor: 1H, 15N and 13C resonance assignments of the apo Sm14-M20(C62V) protein, a mutant of Schistosoma mansoni Sm14
2004 · Thelma A. Pertinhez, Maurício L. Sforça, et al. · Journal of Biomolecular NMR · 13
Works count: 72
Citation count: 1,398
H-index: 19
I10-index: 28
Year
Topic
Type